Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
In Vitro Cellular & Developmental Biology. Animal|December 31, 2024
Efficacy determination of a disinfectant against channel catfish virus by in vitro and in vivo methodsSuja Aarattuthodi, Brian Bosworth, Ganesh Kumar, et al.North American Journal of Aquaculture|November 19, 2019
On-Site Capabilities of a Mobile Laboratory for Aquatic Germplasm CryopreservationWilliam M Childress, Brian Bosworth, Edward Chesney, et al.Inflammatory Bowel Diseases|June 25, 2020
From the American Epicenter: Coronavirus Disease 2019 in Patients with Inflammatory Bowel Disease in the New York City Metropolitan AreaJordan E Axelrad, Lisa Malter, Simon Hong, et al.Molecular Ecology Resources|May 7, 2014
SNP discovery in wild and domesticated populations of blue catfish, Ictalurus furcatus, using genotyping-by-sequencing and subsequent SNP validationChao Li, Geoff Waldbieser, Brian Bosworth, et al.Journal of Graduate Medical Education|June 30, 2020
Swimming With Sharks: Teaching Residents Value-Based Medicine and Quality Improvement Through Resident-Pitched ProjectsMatthew S Durstenfeld, Scott Statman, Kerrilynn Carney, et al.Genetics, Selection, Evolution : GSE|December 15, 2018
Development of genomic predictions for harvest and carcass weight in channel catfishAndre L S Garcia, Brian Bosworth, Geoffrey Waldbieser, et al.Journal of Vascular and Interventional Radiology : JVIR|February 10, 2015
Segmental liver ischemia/infarction after elective transjugular intrahepatic portosystemic shunt creation: clinical outcomes in 10 patientsJorge E Lopera, Venkata Katabathina, Brian Bosworth, et al.Open Forum Infectious Diseases|December 13, 2017
Cost-Effectiveness Analysis of Probiotic Use to Prevent Clostridium difficile Infection in Hospitalized Adults Receiving AntibioticsNicole T Shen, Jared A Leff, Yecheskel Schneider, et al.Antimicrobial Agents and Chemotherapy|November 28, 2012
Rifaximin resistance in Escherichia coli associated with inflammatory bowel disease correlates with prior rifaximin use, mutations in rpoB, and activity of Phe-Arg-β-naphthylamide-inhibitable efflux pumpsVishesh Kothary, Ellen J Scherl, Brian Bosworth, et al.Inflammatory Bowel Diseases|August 25, 2017
Premedication Use in Preventing Acute Infliximab Infusion Reactions in Patients with Inflammatory Bowel Disease: A Single Center Cohort StudyStephanie L Gold, Shirley Cohen-Mekelburg, Yecheskel Schneider, et al.Pageof 3